• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

tetano

Editor, Senior Moderator
Sci Rep. 2018 Dec 20;8(1):18007. doi: 10.1038/s41598-018-36703-7.
[h=1]Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine.[/h] Skibinski DAG[SUP]1,[/SUP][SUP]2[/SUP], Jones LA[SUP]1[/SUP], Zhu YO[SUP]3[/SUP], Xue LW[SUP]1[/SUP], Au B[SUP]1[/SUP], Lee B[SUP]4[/SUP], Naim ANM[SUP]3[/SUP], Lee A[SUP]1[/SUP], Kaliaperumal N[SUP]1[/SUP], Low JGH[SUP]5,[/SUP][SUP]6[/SUP], Lee LS[SUP]7,[/SUP][SUP]8[/SUP], Poidinger M[SUP]4[/SUP], Saudan P[SUP]9[/SUP], Bachmann M[SUP]10[/SUP], Ooi EE[SUP]11[/SUP], Hanson BJ[SUP]12[/SUP], Novotny-Diermayr V[SUP]13[/SUP], Matter A[SUP]13[/SUP], Fairhurst AM[SUP]4[/SUP], Hibberd ML[SUP]3[/SUP], Connolly JE[SUP]14,[/SUP][SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Cell mediated immunity plays a vital role in defense against influenza infection in humans. Less is known about the role of vaccine-induced cell mediated immunity and the cytokine responses elicited. We measured CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell reactivity in human subjects following vaccination with licensed trivalent influenza vaccine and a novel virus-like particle based vaccine. We detected influenza-specific CD4[SUP]+[/SUP] T-cell responses following vaccination with the licensed trivalent influenza vaccine and found that these correlated with antibody measurements. Administration of the novel virus-like particle based vaccine elicited influenza-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T-cell responses and the induction of the cytokines IFN-γ, IL-17A, IL17F, IL-5, IL-13, IL-9, IL-10 and IL-21. Pre-existing cytokine responses influenced the profile of the cytokine response elicited by vaccination. In a subset of individuals the VLP vaccine changed pre-vaccination production of type 2 cytokines such as IL-5 and IL-13 to a post-vaccination type 1 cytokine signature characterized by IFN-γ. A transcriptional signature to vaccination was found to correlate with antibody titer, IFN-γ production by T-cells and expression of a putative RNA helicase, DDX17, on the surface of immune cells.


PMID: 30573748 PMCID: PMC6301966 DOI: 10.1038/s41598-018-36703-7
Free PMC Article
 
Back
Top Bottom